zolmitriptan has been researched along with Light Sensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodick, DW; Friedman, DI; Gelfand, AA; Kellerman, DJ; Schmidt, PC; Tepper, SJ | 1 |
| Fukuuchi, Y; Itoyama, Y; Iwata, M; Morimatsu, M; Nakashima, K; Sakai, F; Sobue, G; Tashiro, K; Tsuji, S | 1 |
2 trial(s) available for zolmitriptan and Light Sensitivity
| Article | Year |
|---|---|
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
Topics: Adult; Biomarkers; Double-Blind Method; Humans; Hyperacusis; Injections, Intradermal; Migraine Disorders; Nausea; Outcome Assessment, Health Care; Oxazolidinones; Photophobia; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2018 |
Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study.
Topics: Adult; Cultural Characteristics; Dose-Response Relationship, Drug; Female; Humans; Hyperacusis; Japan; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Photophobia; Recurrence; Safety; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vomiting | 2002 |